TG Therapeutics Stock Price (NASDAQ:TGTX)

Add to My Stocks
$12.2 $0.45 (3.56%) TGTX stock closing price Feb 16, 2018 (Closing)
Prev Close* : $12.65
Market Cap:
$861.96M
Day Low: $12.06
52 Week Low: $4.50
Open: $12.65
Volume: -
Day High: $12.95
52 Week High: $15.35
Dividend:
0.00

Latest Stock Market News

Latest Articles

TG Therapeutics News - From Partners

TGTX Stockcharts

View TGTX PE ratio, PS ratio stocks charts and compare with peers.
TGTX Chart
Note: Compare TG Therapeutics stock price history with the index and industry peers.

TG Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
4962.35
PB ratio (
price to book ratio
)
11.31

TG Therapeutics Returns

ROE
(return on equity)
-159%

TG Therapeutics Financial Ratios

Asset Turnover
0
Receivables Turnover
3.33
Debt to Equity
0
Dividend Yield
0%

TGTX Industry Peers

Company Price Change (%)
Eagle Pharma (EGRX)64.780.07 (0.11%)
Macrogenics (MGNX)23.30.24 (1.02%)
Fortress Biotech (FBIO)3.510.01 (0.28%)
Gilead Sciences (GILD)80.70.85 (1.04%)
Calithera Biosciences (CALA)8.11.15 (16.55%)
Fortress Biotech (FBIO)3.510.01 (0.28%)
Ligand Pharma (LGND)157.140.04 (0.03%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
NxStage Medical (NXTM)24.621.15 (4.9%)
NanoString Technologies (NSTG)70.21 (3.09%)
Owens & Minor (OMI)16.080.48 (3.08%)
Quidel Corp (QDEL)45.870.77 (1.71%)
OraSure (OSUR)18.280.27 (1.5%)
Chimerix (CMRX)5.020.07 (1.41%)
Fonar (FONR)25.80.35 (1.38%)
Top gainers from Medical Products industry
* As of Feb 17, 2018
CompanyPriceChange (%)
Insys Therapeutics (INSY)7.790.31 (3.83%)
TG Therapeutics (TGTX)12.20.45 (3.56%)
ICU Medical (ICUI)226.24.3 (1.87%)
AtriCure (ATRC)16.960.26 (1.51%)
Agios Pharma (AGIO)77.71.09 (1.38%)
Chembio Diagnostics (CEMI)7.60.1 (1.3%)
Conatus Pharma (CNAT)5.120.06 (1.16%)
Top losers from Medical Products industry
* As of Feb 17, 2018

TG Therapeutics Inc Stock News - Partner Headlines

TG Therapeutics Financial Statements

income statement20162015201420132012
Net Sales or Revenues-----
Net Income-78.25M-62.94M-55.78M-20.47M-18.07M
Total Operating Expense79.11M63.32M55.86M23.11M26.91M
View TG Therapeutics income statement
balance sheet20162015201420132012
Total Assets54.78M113.47M86.74M48.11M22.07M
Total Liabilities18.91M11.89M6.64M8.05M6.52M
Shareholders Equity35.86M101.57M80.1M40.05M15.55M
View TG Therapeutics balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities8.77M2.06M-6.04M4.15M-
Net Cash from (used by) Operating Activities-61.59M-44.69M-35.05M-10.82M-5.18M
Increase (Decrease) in Prop Plant And Equipment-0.34M-0.04M-0.01M-0.01M-
View TG Therapeutics cash flow statement

TG Therapeutics Stock Message Board

An investor needs to spend $12.2 to buy TGTX stock, as the closing TG Therapeutics stock price is $12.2. TG Therapeutics market capitalization is $861.96M and it represents the total market value of TGTX stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing TG Therapeutics stock analysis.

The terms stocks and shares mean the same thing. For Ex: TG Therapeutics stock price and TG Therapeutics share price mean the same thing. 1,194,564 shares were traded with a closing stock price of $12.2 as of Feb 16, 2018, as can be seen from TG Therapeutics stock quote. One can view TG Therapeutics stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. TG Therapeutics dividend per share was 0.00 during the last quarter. TG Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.